In a word, our research shows that the expressions of key genes of sphingolipid metabolism, such as LDHA, CDKN3, SHC1 and BTK, are obviously different from those of non-cancerous tissues in lung adenocarcinoma, and can obviously affect the prognosis of LUAD patients. This evidence concerns the gene CDKN3 and lung adenocarcinoma.